Buspirone in Reducing Shortness of Breath in Patients With Cancer
Status:
Completed
Trial end date:
2011-01-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Buspirone may be effective in reducing dyspnea (shortness of breath) in patients
with cancer who are undergoing chemotherapy.
PURPOSE: Randomized clinical trial to study the effectiveness of buspirone in reducing
shortness of breath in patients who are undergoing chemotherapy for cancer.